Objective To observe the curative effects of lovastatin combined with compound Danshen dripping pills in the treatment of coronary heart disease combined with hyperlipemia. Methods Select 80 patients from March 2011 to September 2012 who were diagnosed with coronary heart disease combined with hyperlipemia, randomly divide them into treatment group and control group ,each of the team had 40 patients. the patients in control group were treated with lovastatin, and the treatment group were treated with lovastatin combined with compound Danshen dripping pills, observe their times of stenocardia happen times and changes of ECG after 30 weeks' treatment, test their TC,LDL-C level in blood, compare the therapeutic effect of two groups. Results The angina remission rate of treatment groups was 87.5%, while the angina remission rate of control groups was 60.0%. It had significant difference between two groups(P<0.05); and the ECG remission rate of treatment groups was 72.5%, while the ECG remission rate of control groups was 42.5%. It had significant difference between two groups(P<0.05). After 30 weeks' treatment, blood lipid level of both two groups were significantly decreased than before, however there was no significant difference between two groups after 30 weeks' treatment. Conclusion The clinical effect of lovastatin combined with compound Danshen dripping pills in the treatment of coronary heart disease combined with hyperlipemia is satisfied.it is worth clinical application.
LovastatinCompound Danshen dripping pillsCoronary heart disease combined with hyperlipemia
NETL
NSTL
万方数据
维普
